The Scientist

» BRCA1 and cell & molecular biology

Most Recent

image: Gene Patents Back in Court

Gene Patents Back in Court

By | June 19, 2012

A public interest legal group has renewed the fight against DNA patenting.

0 Comments

image: Stem Cells from Corpses

Stem Cells from Corpses

By | June 15, 2012

Researchers pull viable cells from bodies that had been dead for more than 2 weeks.

1 Comment

image: Older Dads Have Healthier Kids?

Older Dads Have Healthier Kids?

By | June 11, 2012

New research finds that older men have children and grandchildren with longer telomeres, possibly pointing to health benefits of delayed reproduction.

4 Comments

Contributors

June 1, 2012

Meet some of the people featured in the June 2012 issue of The Scientist.

0 Comments

image: Grading on the Curve

Grading on the Curve

By | June 1, 2012

Actin filaments respond to pressure by forming branches at their curviest spots, helping resist the push.

5 Comments

image: Next Generation: The Brain Bot

Next Generation: The Brain Bot

By | May 29, 2012

A 30-year-old technique to record the electrical activity of neurons gets a robotic makeover.

0 Comments

image: Cancer Exosomes Promote Metastasis

Cancer Exosomes Promote Metastasis

By | May 29, 2012

Vesicles released by melanoma cells stimulate pro-metastasis behaviors in bone marrow cells.

2 Comments

image: 2012 Bio-Art Winners

2012 Bio-Art Winners

By | May 25, 2012

Check out the 10 images that won FASEB's first annual Bio-Art competition.

0 Comments

image: Could Stem Cells Cure MS?

Could Stem Cells Cure MS?

By | May 23, 2012

A growth factor isolated from human stem cells shows promising results in a mouse model of multiple sclerosis.

1 Comment

image: DNA Hard Drive

DNA Hard Drive

By | May 23, 2012

Researchers design the first rewritable biological data storage system.

2 Comments

Popular Now

  1. How Plants Evolved Different Ways to Make Caffeine
  2. Thomson Reuters Predicts Nobelists
    The Nutshell Thomson Reuters Predicts Nobelists

    According to citation statistics, researchers behind programmed cell death pathways and CRISPR/Cas9 are among those in line for Nobel Prizes this year.

  3. Monsanto Buys Rights to CRISPR
    The Nutshell Monsanto Buys Rights to CRISPR

    The US agribusiness secures a global, nonexclusive licensing agreement from the Broad Institute to use the gene-editing technology for agricultural applications.

  4. Reviewing Results-Free Manuscripts
    The Nutshell Reviewing Results-Free Manuscripts

    An open-access journal is trialing a peer-review process in which reviewers do not have access to the results or discussion sections of submitted papers.

RayBiotech